PharmaShots | Incisive News in 3 Shots

Subscribe Now

Relapsed or Refractory Diffuse Large B-Cell Lymphoma

MorphoSys and Incyte's Minjuvi (tafasitamab) + Lenalidomide Receive EC's Approval for the Treatment of R/R DLBCL

MorphoSys and Incyte's Minjuvi (tafasitamab) + Lenalidomide Receive EC's Approval for the Treatment of R/R DLBCL

August 27, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us